Kallee, S.; Scharf, C.; Schatz, L.M.; Paal, M.; Vogeser, M.; Irlbeck, M.; Zander, J.; Zoller, M.; Liebchen, U.
Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients. Pharmaceutics 2022, 14, 1920.
https://doi.org/10.3390/pharmaceutics14091920
AMA Style
Kallee S, Scharf C, Schatz LM, Paal M, Vogeser M, Irlbeck M, Zander J, Zoller M, Liebchen U.
Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients. Pharmaceutics. 2022; 14(9):1920.
https://doi.org/10.3390/pharmaceutics14091920
Chicago/Turabian Style
Kallee, Simon, Christina Scharf, Lea Marie Schatz, Michael Paal, Michael Vogeser, Michael Irlbeck, Johannes Zander, Michael Zoller, and Uwe Liebchen.
2022. "Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients" Pharmaceutics 14, no. 9: 1920.
https://doi.org/10.3390/pharmaceutics14091920
APA Style
Kallee, S., Scharf, C., Schatz, L. M., Paal, M., Vogeser, M., Irlbeck, M., Zander, J., Zoller, M., & Liebchen, U.
(2022). Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients. Pharmaceutics, 14(9), 1920.
https://doi.org/10.3390/pharmaceutics14091920